Abstract:Objective To establish and validate a modified rat thromboembolic stroke model.Methods After taking femoral arterial blood and mixing it with thrombin,they were injected into PE-50 catheter for preparing in vitro thrombosis in 60 Sprague-Dawley rats.A thromboembolic cerebral ischemia model induced by catheterization of the right external carotid artery and the small blood clot emboli were injected into the internal carotid arteries.Thirty rats were randomly divided into a large number of emboli group (n =10 with 12 emboli),a median number of emboli group (n =10 with 10 emboli) and a small number of emboli group (n =10 with 8 emboli).Two hours after embolus injection,the neurological deficit score was performed and the success rate of the model was compared in all groups.Twenty-four hours after embolus injection,the rats were sacrificed and the brains were removed for 2,3,5-triphenyltetrazolium chloride staining.The hemorrhage,infarct volume,bleeding incidence and mortality after cerebral infarction were evaluated.The high success rates of the modeling in the emboli groups were selected and they were randomly divided into either a normal saline group (n =12) or a recombinant tissue-type plasminogen activator (rtPA) group (n =12).The rats were given normal saline and rtPA at 3 hours after embolus injection.Before embolus injection and 2,6,12 and 24 hours after embolus injection,the neurological scores were performed respectively; 24 hours after embolus injection,the rats were sacrificed and the brains were removed for 2,3,5-triphenyltetrazolium chloride staining.The hemorrhage rate,infarction size,degree of cerebral edema,and blood-brain barrier permeability were evaluated.Results Only 40％ of rats had neurological deficits in the small number of emboli group,and the infarct volume was only 10.54 ± 2.82％.The success rates in the median and large number of emboli groups were 80％ and 100％ respectively.They were all significantly higher than those in the small number of emboli group (P =0.011 ).The infarct volume was also significantly greater than that in the small number of emboli group (F =40.897,P =0.000).After administration of rtPA,the mean survival time of the rats in the large number of emboli group was less than 24 hours,so the median number of emboli group was selected to study the thrombolytic effect of rtPA.The infarct volume and neurological function score in the rtPA group were improved significantly compared to the normal saline group (t =7.728,P =0.000),while there were no significant differences in the hemorrhage rate,degree of brain edema and blood-brain barrier permeability between the 2 groups.Conclusions The stability and reproducibility were good in the modified thromboembolic cerebral ischemia model injected with 10 emboli,the neurological function was improved significantly after thrombolysis,and it was applicable to the experimental study of pathophysiology of cerebral ischemia and thrombolytic therapy.

A Rat Model of Studying Tissue-Type Plasminogen Activator Thrombolysis in Ischemic Stroke with Diabetes

A Clinically Relevant Model of Focal Embolic Cerebral Ischemia by Thrombus and Thrombolysis in Rhesus Monkeys.

A modified rat model of thromboembolism for study of hemorrhagic transformation in stroke after intrave-nous thrombolysis

Endovascular ischemic stroke models of adult rhesus monkeys: a comparison of two endovascular methods

Diabetes Mellitus/Poststroke Hyperglycemia: a Detrimental Factor for tPA Thrombolytic Stroke Therapy

Improving Stroke Outcomes in Hyperglycemic Mice by Modulating tPA/NMDAR Signaling to Reduce Inflammation and Hemorrhages

A Modified Thromboembolic Stroke Model of Rat Suitable for the Delayed Thrombolytic Therapy

Imaging of a clinically relevant stroke model: glucose hypermetabolism revisited.

Improvement of a rat thromboembolic stroke model for thrombolysis study

Diabetic microangiopathy: impact of impaired cerebral vasoreactivity and delayed angiogenesis after permanent middle cerebral artery occlusion on stroke damage and cerebral repair in mice

Abstract WMP115: Rapid Vascular Complement Activation: A Key Driver of Blood-Brain Barrier Disruption in Ischemic Stroke With Acute Hyperglycemia

Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by Increasing superoxide production

Abstract T P233: Diabetes Potentiates Ischemia-reperfusion (I/R) Brain Injury: Role for Methylglyoxal, Glutathione, and Cerebral Microvascular Thrombosis

Rodent Models of Ischemic Stroke: A Useful Tool for Stroke Drug Development

Hemorrhagic Transformation Induced by Acute Hyperglycemia in a Rat Model of Transient Focal Ischemia.

Rodent Models for Intravascular Ischemic Cerebral Infarction: a Review of Influencing Factors and Method Optimization

Early Increased Bradykinin 1 Receptor Contributes to Hemorrhagic Transformation after Ischemic Stroke in Type 1 Diabetic Rats

Hemorrhagic Transformation Induced by Mechanical Reperfusion and Acute Hyperglycemia in a Rat Ischemic Model

Altered Jagged1-Notch1 Signaling in Enhanced Dysfunctional Neovascularization and Delayed Angiogenesis after Ischemic Stroke in HFD/STZ Induced Type 2 Diabetes Rats

A Modified Method to Reduce Variable Outcomes in a Rat Model of Four-Vessel Arterial Occlusion

A Novel Improved Thromboembolism-Based Rat Stroke Model That Meets the Latest Standards in Preclinical Studies